119 related articles for article (PubMed ID: 2167508)
21. Five-year results of a randomized clinical trial comparing modified radical mastectomy and extended radical mastectomy for stage II breast cancer.
Morimoto T; Monden Y; Takashima S; Itoh S; Kimura T; Yamamoto H; Kitamura M; Inui K; Tanaka N; Nagano T
Surg Today; 1994; 24(3):210-4. PubMed ID: 8003862
[TBL] [Abstract][Full Text] [Related]
22. Prognosis and treatment in minimal breast cancer.
Frazier TG; Copeland EM; Gallager HS; Paulus DD; White EC
Am J Surg; 1977 Jun; 133(6):697-701. PubMed ID: 194494
[TBL] [Abstract][Full Text] [Related]
23. Breast recurrence and survival related to primary tumor location in patients undergoing conservative surgery and radiation for early-stage breast cancer.
Fowble B; Solin LJ; Schultz DJ; Weiss MC
Int J Radiat Oncol Biol Phys; 1992; 23(5):933-9. PubMed ID: 1322386
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for lymph node metastases in breast ductal carcinoma in situ with minimal invasive component.
Wasserberg N; Morgenstern S; Schachter J; Fenig E; Lelcuk S; Gutman H
Arch Surg; 2002 Nov; 137(11):1249-52. PubMed ID: 12413311
[TBL] [Abstract][Full Text] [Related]
25. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
28. Radical mastectomy with parasternal node dissection or radiation to the parasternal region for breast cancer of medial or central location.
Shiba E; Miyauchi K; Kobayashi T; Takai S; Mori T
Surg Today; 1992; 22(2):124-7. PubMed ID: 1498490
[TBL] [Abstract][Full Text] [Related]
29. Extracapsular extension in positive axillary lymph nodes in female breast cancer patients. Patterns of failure and indications for postoperative locoregional irradiation.
Stranzl H; Mayer R; Ofner P; Peintinger F; Prettenhofer U; Hackl A
Strahlenther Onkol; 2004 Jan; 180(1):31-7. PubMed ID: 14704842
[TBL] [Abstract][Full Text] [Related]
30. Outcome of conservative therapy for invasive breast cancer by histologic subtype.
Weiss MC; Fowble BL; Solin LJ; Yeh IT; Schultz DJ
Int J Radiat Oncol Biol Phys; 1992; 23(5):941-7. PubMed ID: 1322387
[TBL] [Abstract][Full Text] [Related]
31. Surgical management of early stage invasive breast cancer: a practice guideline.
McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
[TBL] [Abstract][Full Text] [Related]
32. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer.
Fowble B; Hanlon A; Freedman G; Nicolaou N; Hoffman J; Sigurdson E; Boraas M; Torosian M; Goldstein L
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):883-94. PubMed ID: 10863056
[TBL] [Abstract][Full Text] [Related]
33. Extent of axillary dissection preceding irradiation for carcinoma of the breast.
Schwartz GF; D'Ugo DM; Rosenberg AL
Arch Surg; 1986 Dec; 121(12):1395-8. PubMed ID: 3024603
[TBL] [Abstract][Full Text] [Related]
34. The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer.
Wong JH; Kopald KH; Morton DL
Arch Surg; 1990 Oct; 125(10):1298-301; discussion 1301-2. PubMed ID: 2171453
[TBL] [Abstract][Full Text] [Related]
35. [Changes in radical surgery of breast carcinoma in the last 20 years].
Mättig H; Stubert B; Schmerler R
Zentralbl Chir; 1997; 122(2):92-6. PubMed ID: 9173764
[TBL] [Abstract][Full Text] [Related]
36. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.
Willner J; Kiricuta IC; Kölbl O
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):853-63. PubMed ID: 9128962
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcome in patients with four or more positive lymph nodes treated with conservative surgery and radiation therapy.
Mehta K; Haffty BG
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(4):679-85. PubMed ID: 8690633
[TBL] [Abstract][Full Text] [Related]
38. Axillary lymph node dissection for intraductal breast carcinoma--is it indicated?
Silverstein MJ; Rosser RJ; Gierson ED; Waisman JR; Gamagami P; Hoffman RS; Fingerhut AG; Lewinsky BS; Colburn W; Handel N
Cancer; 1987 May; 59(10):1819-24. PubMed ID: 3030529
[TBL] [Abstract][Full Text] [Related]
39. [Radiation-surgical treatment of cancer of the female breast].
Di Pietrantonj F; Proietti A; Cardinali M; Fabbietti L
Minerva Med; 1992 Jun; 83(6):333-46. PubMed ID: 1321369
[TBL] [Abstract][Full Text] [Related]
40. Locoregional recurrence in patients with one to three positive axillary nodes after mastectomy without adjuvant radiotherapy.
Cheng JC; Chen CM; Liu MC; Tsou MH; Yang PS; Cheng SH
J Formos Med Assoc; 2000 Oct; 99(10):759-65. PubMed ID: 11061070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]